In this study, we developed a novel logistic regression model based on P53, MSH2, and Tm‐4 combined with inflammatory factors and life‐history traits to easily estimate AFP‐Negative HCC patients and validated this model in 3 external validation cohorts. Here, TP53 is linked to hepatocellular carcinoma.